维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Kurian AW"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	A cost-effectiveness analysis of adju- vant trastuzumab regimens in early HER2/neu-positive breast cancer 显示文摘	Kurian AW Thompson RN Gaw AF	2007	J Clin Onco12007，25，：	1
	2	Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers显示文摘	Kurian AW Sigal BM Plevritis SK	2010	J Clin Oncol2010，28，2：	1
	3	Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers显示文摘	Staton AD Kurian AW Cobb K		0，，02：	1
	4	Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups显示文摘	Kurian AW Fish K Shema SJ	2010	Breast Cancer Res2010，12，6：	1
	5	Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry显示文摘	~elli ML Chang ET Kurian AW	2011	Breast Cancer Res Treat2011，127，2：	1
	6	Cost-effectivenass of screening BRCA 1/2 mutation carriers with breast magnetic resonance imaging 显示文摘	Plevritis SK Kurian AW Sigal BM	2006	JAMA2006，295，20：	1
	7	Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers显示文摘	Kurian AW Sigal BM Plevritis SK	2010	J Clin Oncol2010，28，2：	1
	8	A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neupositive breast cancer 显示文摘	Kurian AW Thompson RN Gaw AF	2007	J Clin Oncol2007，25，6：	1
	9	Histologic types of epithelial ovarian cancer: have they different risk factors? 显示文摘	Kurian AW Balise RR McGuire V	2005	Gynecol Oncol2005，96，2：	1
	10	Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment显示文摘	Desmond A Kurian AW Gabree M	2015	JAMA Oncol2015，1，：	1
	11	Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998 - 2011 显示文摘	Kurian AW Lichtensztajn DY Keegan TH	2014	JAMA2014，312，9：	1
	12	Asian ethnicity and breast cancer subtypes: a study from the California cancer reg- istry显示文摘	Telli ML Chang ET Kurian AW	2011	Breast Cancer Res Treat2011，127，2：	1
	13	Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers 显示文摘	Kurian AW Sigal BM Plewitis SK	2010	J Clin Oncol2010，28，2：	1
	14	Patterns and predictors of breast cancer chemotherapy use in Kaiser PermanenteNorthern California, 2004-2007显示文摘	Kurian AW Lichtensztajn DY Keegan TH	2012	Breast Cancer Res Treat2012，137，1：	1
	15	A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer显示文摘	Kurian AW Thompson RN Gaw AF	2007	J Clin Oncol2007，25，6：	1
	16	Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry 显示文摘	Telli ML Chang ET Kurian AW	2013	Breast Cancer Res Treat2013，127，2：	1
	17	Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma 显示文摘	Hartman AR Daniel BL Kurian AW	2004	Cancer2004，100，3：	1
	18	Cancer risk reduction and reproductive concerns in female BRCA1,2 mutation carriers 显示文摘	Staton AD Kurian AW Cobb K	2008	Fam Cancer2008，7，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费